Peptides by goal · Weight, muscle and energy
Peptides for muscle growth, ranked by evidence
Checked against our library and study pagesPublished by PepVault
Of the 11 compounds in our library linked to muscle growth, 4 have been studied in people for it, 3 have animal or lab evidence only, and 4 rest on community reports alone. HCG ranks first, with 1 of our study pages in people on muscle growth.
Peptides and muscle growth
Muscle is built mainly by training, enough protein and sleep, and peptides are sold as a way to push that further. The ones linked to muscle mostly work through growth hormone and IGF-1, or by blocking myostatin, a brake on muscle growth; very few have been tested for muscle in healthy people.
For muscle, check what a study actually measured: lean mass on a scan is not the same as strength, and a result in animals or in older or ill people may not carry over to a healthy adult who trains.

Model. Individual results vary.
The 11 compounds, ranked by evidence
Studied in people
4 compounds
HCG
#1 · Human studiesHCG is the pregnancy hormone, and in men it does the job of luteinizing hormone: it tells the testes to keep making testosterone. For muscle growth it has been studied in people: 1 of our study pages in people is about it.
HCG: about 2 kg more lean mass but no strength gain in older menOur study page: randomized trial in people, 2002
Why it is here: 1 of our study pages is about this goal.
Tesamorelin
#2 · Human studiesThe only GHRH analog currently FDA-approved (to reduce excess abdominal fat in HIV lipodystrophy). For muscle growth it has been studied in people: 1 of our study pages in people is about it.
Tesamorelin: denser, larger trunk muscles at 26 weeks in HIVOur study page: randomized trial in people, 2019
Why it is here: 1 of our study pages is about this goal.
MK-677
#3 · Human studiesNot actually a peptide — it's a small molecule you take orally that mimics ghrelin to stimulate GH release. In trials, lean mass rose over the first year, so if nutrition is dialed, gains show up here. For muscle growth it has been studied in people: 1 of our study pages in people is about it.
MK-677: fat-free mass rose 1.1 kg vs -0.5 kg on placebo at 1 yearOur study page: randomized trial in people, 65 people, 2008
Why it is here: its library entry lists “Muscle support” and 1 of our study pages is about this goal.
Follistatin-344
#4 · Human studiesMyostatin is the brake on muscle growth — the protein that explains double-muscled cattle when it is missing. Follistatin is the body's own brake-release: it binds myostatin, and activin A as well, and mice over-expressing it grow muscle like myostatin-knockout mice. For muscle growth the trials in people that its library entry cites put it on this rung, though none of our study pages covers this goal yet.
The library’s research note “Bigger muscle, unchanged function” rests on studies in people.
Why it is here: its library entry lists “Myostatin binding” and “Muscle growth (animal data)”.
Animal or lab studies only
3 compounds
PEG-MGF
#5 · Animal or labWhen muscle is loaded or damaged, the IGF-1 gene can be read a different way, producing a variant with an extra tail. The 24-amino-acid tail of IGF-1Ec, a splice variant of the IGF-1 gene that muscle turns up after loading or injury; the tail is cut off when the gene product is processed, and that fragment is what is sold as mechano growth factor. For muscle growth the evidence is from animals or cells only: 2 study pages of ours, in C2C12 cells, primary human skeletal muscle myoblasts, primary mouse skeletal muscle stem cells and cardiac myocytes and human muscle cells.
PEG-MGF (MGF): no rise in mouse or human muscle cell proliferationOur study page: cell study in C2C12 cells, primary human skeletal muscle myoblasts, primary mouse skeletal muscle stem cells and cardiac myocytes, 2014
Why it is here: its library entry lists “Muscle repair (animal data)” and “Satellite cells” and 2 of our study pages are about this goal.
MOTS-c
#6 · Animal or labA peptide encoded by your mitochondrial DNA, the energy-producing organelles inside every cell. For muscle growth the evidence is from animals or cells only: 1 study page of ours, in mice.
MOTS-c prevented muscle atrophy, raised muscle glucose uptake in miceOur study page: animal study in mice, 2024
Why it is here: 1 of our study pages is about this goal.
IGF-1 LR3
#7 · Animal or labIGF-1 is the growth factor your liver and muscles make when growth hormone arrives — the messenger that does much of GH's building work. Commonly reported: fuller muscles and quicker recovery, hunger, and the shaky, sweaty, light-headed feeling of a blood-sugar dip within an hour or two of a dose. For muscle growth the evidence its library entry cites is from animal studies, and none of our study pages covers it yet.
The library’s research note “What IGF-1 LR3 is built on” rests on animal studies.
Why it is here: its library entry lists “Muscle growth (animal data)”.
Community reports only
4 compounds
HGH
#8 · Reports onlyRecombinant human growth hormone — an identical copy of the GH your pituitary makes. It stimulates IGF-1 production, fat burning, muscle protein synthesis and tissue repair. For muscle growth it rests on community reports: no study page of ours covers this goal, and the library lists it under “Muscle growth”.
Why it is here: its library entry lists “Muscle growth”.
GHRP-2
#9 · Reports onlyA potent growth hormone secretagogue: more potent than Ipamorelin but less selective, so along with GH and IGF-1 it also raises cortisol and prolactin. For muscle growth it rests on community reports: no study page of ours covers this goal, and the library lists it under “Muscle growth”.
Why it is here: its library entry lists “Muscle growth”.
GHRP-6
#10 · Reports onlyOne of the first growth hormone releasing peptides, with one standout effect: strong appetite stimulation. For muscle growth it rests on community reports: no study page of ours covers this goal, and the library lists it under “Bulking support”.
Why it is here: its library entry lists “Bulking support”.
5-Amino-1MQ
#11 · Reports onlyA small molecule (not a peptide) that blocks the NNMT enzyme in fat cells, which raises NAD+ and pushes fat cells toward burning energy. In cultured fat cells it raises NAD+ and SAM levels; in obese mice it cut body weight and fat without reducing food intake, and with a reduced-calorie diet lean mass made up a larger share of body weight. For muscle growth it rests on community reports: no study page of ours covers this goal, and the library lists it under “Lean mass preservation”.
Why it is here: its library entry lists “Lean mass preservation”.
How they differ
Route, dosing frequency and half-life as each library entry records them, for the 11 compounds in ranked order.
| Compound | Evidence | Route | Dosing frequency | Half-life |
|---|---|---|---|---|
| HCG | Human studies | SubQ injection, IM injection | 2x weekly | ~33 hours |
| Tesamorelin | Human studies | SubQ injection | Daily | ~8–11 min |
| MK-677 | Human studies | Oral | Daily, before bed | ~24 hours |
| Follistatin-344 | Human studies | SubQ injection | Daily | Not measured in people: no human pharmacokinetic study of injected follistatin has been published. In rats, labelled follistatin given into a vein cleared in two phases, about 4 minutes then about 2 hours, and collected in the liver |
| PEG-MGF | Animal or lab | SubQ injection, IM injection | 2–3x weekly, post-workout | Not measured: no pharmacokinetic study of PEG-MGF has been published, in people or in animals. The unmodified peptide is broken down quickly, and for a mouse heart study researchers stabilized it chemically — amidating one end and swapping two arginines for their mirror-image form |
| MOTS-c | Animal or lab | SubQ injection, IM injection | 2–3× weekly | Hours |
| IGF-1 LR3 | Animal or lab | SubQ injection | Daily (community protocols: training days) | Not measured in people: no human pharmacokinetic study of IGF-1 LR3 has been published. In rats it cleared from plasma about ten times faster than IGF-1 |
| HGH | Reports only | SubQ injection | Daily SubQ injection. | ~3-4 hours |
| GHRP-2 | Reports only | SubQ injection | 2–3x daily | ~30 min |
| GHRP-6 | Reports only | SubQ injection | 2–3x daily | ~20 min |
| 5-Amino-1MQ | Reports only | Oral | Daily | Unknown |
- Evidence
- Human studies
- Route
- SubQ injection, IM injection
- Dosing
- 2x weekly
- Half-life
- ~33 hours
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Daily
- Half-life
- ~8–11 min
- Evidence
- Human studies
- Route
- Oral
- Dosing
- Daily, before bed
- Half-life
- ~24 hours
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Daily
- Half-life
- Not measured in people: no human pharmacokinetic study of injected follistatin has been published. In rats, labelled follistatin given into a vein cleared in two phases, about 4 minutes then about 2 hours, and collected in the liver
- Evidence
- Animal or lab
- Route
- SubQ injection, IM injection
- Dosing
- 2–3x weekly, post-workout
- Half-life
- Not measured: no pharmacokinetic study of PEG-MGF has been published, in people or in animals. The unmodified peptide is broken down quickly, and for a mouse heart study researchers stabilized it chemically — amidating one end and swapping two arginines for their mirror-image form
- Evidence
- Animal or lab
- Route
- SubQ injection, IM injection
- Dosing
- 2–3× weekly
- Half-life
- Hours
- Evidence
- Animal or lab
- Route
- SubQ injection
- Dosing
- Daily (community protocols: training days)
- Half-life
- Not measured in people: no human pharmacokinetic study of IGF-1 LR3 has been published. In rats it cleared from plasma about ten times faster than IGF-1
- Evidence
- Reports only
- Route
- SubQ injection
- Dosing
- Daily SubQ injection.
- Half-life
- ~3-4 hours
- Evidence
- Reports only
- Route
- SubQ injection
- Dosing
- 2–3x daily
- Half-life
- ~30 min
- Evidence
- Reports only
- Route
- SubQ injection
- Dosing
- 2–3x daily
- Half-life
- ~20 min
- Evidence
- Reports only
- Route
- Oral
- Dosing
- Daily
- Half-life
- Unknown
Compared side by side
Questions
Which peptides have been studied in people for muscle growth?
4 of the 11 on this page: HCG, Tesamorelin, MK-677 and Follistatin-344. The rest have animal or lab evidence or community reports only.
Is any peptide FDA-approved for muscle growth?
No. None of the 11 compounds on this page has an FDA approval for a use related to muscle growth in its library entry.
Which is the best-studied peptide for muscle growth?
By our count it is a tie: HCG, Tesamorelin and MK-677 each have 1 study page in people about muscle growth, and none has more.
Which ones have only animal or lab evidence for muscle growth?
3 compounds: PEG-MGF (C2C12 cells, primary human skeletal muscle myoblasts, primary mouse skeletal muscle stem cells and cardiac myocytes and human muscle cells), MOTS-c (mice) and IGF-1 LR3. A result in animals or cells often doesn’t hold in people.
How are the peptides for muscle growth taken?
Of the 11 compounds for muscle growth, 9 are taken by injection, 2 by mouth, as their library entries list (some have more than one route). The table above gives each one’s route, how often it is dosed and its half-life.
How do the peptides for muscle growth compare with each other?
We compare 5 pairs of them side by side: GHRP-2 vs GHRP-6, HGH vs MK-677, HGH vs Tesamorelin, HGH vs IGF-1 LR3 and IGF-1 LR3 vs PEG-MGF.
How we ranked them
Each compound is placed on the highest rung its evidence for this goal reaches. First come compounds the FDA has approved for a use related to the goal, and only where the library entry says so. Next come compounds studied in people for it (in one of our study pages, or in the trials a research note of the library entry rests on), then those with animal or lab studies only, and last those resting on community reports alone.
Within a rung, compounds are ordered by how many of our study pages in people cover the goal, then by the library’s overall research rating, then by the number of study pages of any kind. A compound is on this page only because its library entry lists a use for this goal, says so in its description, or one of our study pages is about it; the reason is printed with each one.
This is a ranking of evidence, not of results, and not advice on what anyone should take.